Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005

被引:31
作者
Atrasheuskaya, A. V. [1 ]
Kulak, M. V. [1 ]
Neverov, A. A. [1 ]
Rubin, S. [2 ]
Ignatyev, G. M. [1 ]
机构
[1] State Res Ctr Virol & Biotechnol Vector, Lab Immunol Safety, Koltsov 630559, Novosibirsk Reg, Russia
[2] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA
关键词
measles; Russia; genotyping; vaccine failure; neutralizing titers;
D O I
10.1016/j.vaccine.2008.02.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
White the proportion of measles cases in vaccinees is expected to increase as vaccine coverage increases, such cases must be carefully investigated. The present study was conducted to examine possible contributions to vaccine failures (VFs) and to genetically characterize measles virus (MV) strains circulating in Novosibirsk, Russia during 2000-2005. Totally, 27 adult measles patients admitted to a regional hospital were prospectively enrolled in our study. Genetic characterization of the MV strains revealed circulation of genotypes A, D4 and D6 between 2000 and 2003 years; a genotype D6 MV was associated with the 2005 measles outbreak. Based on IgG avidity testing, half of the vaccinated patients demonstrated evidence of secondary vaccine failure (SVF). Patients, representing both levels of vaccine failure in our study were characterized by the tack of protective titers of neutralizing antibodies against circulating MVs, despite high IgG levels in many cases and high IgG avidity in SVF cases. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2111 / 2118
页数:8
相关论文
共 57 条
[1]  
[Anonymous], 2005, BIOPOLYMERS
[2]   Measles in Minsk, Belarus, 2001-2003: Clinical, virological and serological parameters [J].
Atrasheuskaya, AV ;
Blatun, EM ;
Neverov, AA ;
Kameneva, SN ;
Maksimov, NL ;
Karpov, IA ;
Ignatyev, GM .
JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (03) :179-185
[3]   Acute infectious mononucleosis and coincidental measles virus infection [J].
Atrasheuskaya, AV ;
Kameneva, SN ;
Neverov, AA ;
Ignatyev, GM .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (02) :160-164
[4]   Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination [J].
Bautista-López, N ;
Ward, BJ ;
Mills, E ;
McCormick, D ;
Martel, N ;
Ratnam, S .
VACCINE, 2000, 18 (14) :1393-1401
[5]   Neutralizing B cell response in measles [J].
Bouche, FB ;
Ertl, OT ;
Muller, CP .
VIRAL IMMUNOLOGY, 2002, 15 (03) :451-471
[6]  
CHISTENKO GN, 2002, BELARUSSIAN MED J, V3, P8
[7]  
Damien B, 1998, J MED VIROL, V56, P85, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt
[8]  
85::AID-JMV14&gt
[9]  
3.0.CO
[10]  
2-V